First person cured of HIV dies after five-month battle with leukemia
After a five-month battle with leukemia, the first known person to be cured of HIV has died of cancer, according to the International AIDS Society.
Read More
aids
Hundreds of thousands still dying from AIDS as search for vaccine continues
As people around the world commemorate World AIDS Day, in many countries, the disease is still cutting lives short at an alarming rate. So what’s needed to address this global health issue?
Read More
ViiV Healthcare HIV treatment shows success in 2-month treatment trial
“Approval of this regimen would mark a significant change in the HIV treatment paradigm,” says the head of R&D at ViiV Healthcare.
Read More
Thousands of uninsured people to receive HIV prevention drug free of charge
Hundreds of thousands of uninsured people may soon have access to medication meant to curb the HIV epidemic.
Read More
UNC professor hails study showing drug treatment can help end AIDS pandemic
The risk of passing on the HIV virus is completely eliminated by effective drugs treatment, a landmark study has shown, in a significant boost to the prospects of ending the AIDS pandemic. And a UNC professor is hailing the findings.
Read More
Results of monthly shots to combat AIDS in trials boosts ViiV Healthcare’s combo treatment
Monthly shots of HIV drugs worked as well as daily pills to control the virus that causes AIDS in two large international tests, researchers reported Thursday. That’s good news for ViiV Healthcare, which has a large operation in RTP.
Read More
Duke researchers believe new approach can improve HIV vaccine design
In the quest to develop an effective HIV vaccine, researchers have focused attention on identifying and targeting the region of the virus’s outer envelope where a lineage of antibodies are able to dock and neutralize the virus. That focus may change due to research at Duke University.
Read More
Remembering HIV pioneers: In new book, RTI exec gathers stories so they won’t ‘get lost’
Dr. Wendee Wechsberg has been on a mission over the last several years: Gathering stories of people involved in the war against HIV over the past three decades so their battles and achievements won’t “get lost.”
Read More
GSK’s ViiV Healthcare reports ‘landmark’ results for drug to control HIV
ViiV Healthcare, which has researchers based in RTP, is reporting what it calls “landmark” late-stage clinical trial results for its two-drug combo that it says is “demonstrating the ability to control HIV.”
Read More
